Department of Pathology and Microbiology, Aga Khan University Hospital, Karachi, Pakistan.
J Clin Pathol. 2012 Jul;65(7):631-4. doi: 10.1136/jclinpath-2012-200714. Epub 2012 Apr 11.
To report the exceedingly rare occurrence of oligodendroglioma in the glial component of ovarian teratomas.
Six cases of oligodendrogliomas arising in the glial component of ovarian teratomas were studied and the literature was reviewed. Immunohistochemistry was performed by the Flex technique.
The ages of the patients ranged from 12 to 28 years (mean 21 years). Four tumours were located in the right and one in the left ovary. The size of the ovarian cysts ranged from 7 cm to 29 cm (mean 19.6 cm). Four cases arose in immature and two cases in mature teratomas. In all cases, oligodendroglioma was WHO grade II. On immunohistochemistry, glial fibrillary acidic protein stain was positive in all cases. The Mib 1 (Ki 67) proliferative index was low and the tumour cells were negative for synaptophysin. Follow-up was available in five patients and ranged from 1 to 42 months. Two patients died of disease after 1 and 36 months of diagnosis, respectively. In both these cases oligodendroglioma arose in an immature teratoma. The remaining three patients are alive with a follow-up of 4-42 months.
Oligodendroglioma arising in the glial component of ovarian teratomas is exceedingly rare. Ovarian teratomas should be extensively sampled and carefully evaluated to rule out the possibility of a glial tumour. This is the single and largest series of oligodendrogliomas arising in ovarian teratomas. The prognosis is good for oligodendrogliomas arising in mature teratomas compared with those arising in immature teratomas, although long-term follow-up is needed to determine the exact behaviour.
报告卵巢畸胎瘤胶质成分中少突胶质细胞瘤的罕见发生。
研究了 6 例起源于卵巢畸胎瘤胶质成分的少突胶质细胞瘤,并复习了文献。采用 Flex 技术进行免疫组织化学染色。
患者年龄 12-28 岁,平均 21 岁。4 例肿瘤位于右侧卵巢,1 例位于左侧卵巢。卵巢囊肿大小 7-29cm,平均 19.6cm。4 例发生在未成熟畸胎瘤,2 例发生在成熟畸胎瘤。所有病例均为少突胶质细胞瘤 WHO 分级 II 级。免疫组织化学染色显示,所有病例胶质纤维酸性蛋白染色阳性。Mib-1(Ki-67)增殖指数低,肿瘤细胞突触素阴性。5 例患者获得随访,随访时间 1-42 个月。2 例患者分别在诊断后 1 个月和 36 个月死亡,均死于疾病。这两例少突胶质细胞瘤均起源于未成熟畸胎瘤。其余 3 例患者存活,随访时间 4-42 个月。
卵巢畸胎瘤胶质成分中少突胶质细胞瘤极为罕见。卵巢畸胎瘤应广泛取材并仔细评估,以排除胶质肿瘤的可能。这是单一且最大的一组起源于卵巢畸胎瘤的少突胶质细胞瘤。与起源于未成熟畸胎瘤的少突胶质细胞瘤相比,起源于成熟畸胎瘤的少突胶质细胞瘤预后较好,但需要长期随访以确定确切的行为。